Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testicular cancer

R T Oliver1

  • 1Medical School, Royal London Hospital, UK.

Current Opinion in Oncology
|May 1, 1994
PubMed
Summary
This summary is machine-generated.

Advances in DNA technology aid testicular cancer research, focusing on genetic markers and treatment strategies. Studies highlight fertility concerns and late treatment effects, emphasizing personalized medicine approaches for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Single-agent carboplatin AUC10 for metastatic seminoma with IGCCCG good prognosis disease; a feasibility study of the Orchid Clinical Trials Group.

Annals of oncology : official journal of the European Society for Medical Oncology·2010
Same author

Aphorisms in cancer surgery.

Annals of the Royal College of Surgeons of England·2009
Same author

Prognostic factors for renal cell carcinoma.

Cancer treatment reviews·2008
Same author

Introduction: Clonal evolution in bladder cancer: a scientific and clinical perspective.

Cancer surveys·2004
Same author

Squamous change in bladder cancer and its relevance to understanding clonal evolution in development of bladder cancer.

Cancer surveys·2004
Same author

Malignancy associated papillomaviruses and morphology of human bladder cancer.

Cancer surveys·2004
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Genetics and Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • The Human Genome Project has significantly advanced DNA study technologies.
  • These techniques are increasingly applied to testicular cancer research.
  • Key areas include genetic markers and treatment-related late effects.

Purpose of the Study:

  • To review recent advancements in testicular cancer research using novel DNA technologies.
  • To discuss the implications of genetic findings on diagnosis and treatment.
  • To highlight ongoing debates in patient management and risk stratification.

Main Methods:

  • Application of double-fluorescence in situ hybridization for identifying isochrome 12p.
  • Loss-of-heterozygosity studies to identify candidate suppressor genes.

Related Experiment Videos

  • Analysis of late effects of chemotherapy (etoposide) and radiotherapy (seminoma).

    • Main Results:

    • Identification of the germ cell tumor marker isochrome 12p.
    • Potential identification of a suppressor gene on chromosome 12p.
    • Confirmation of acute myeloid leukemia and stomach cancer as late effects of specific treatments.
    • Disappointing results from trials altering standard chemotherapy regimens (cisplatin, carboplatin, bleomycin).

    Conclusions:

    • Genetic studies are crucial for understanding testicular cancer.
    • Fertility preservation and minimizing late treatment effects are key concerns.
    • Risk stratification using biomarkers like lactate dehydrogenase-1 and specialized care are vital for improving patient outcomes.